Universal Ibogaine Inc
XTSX:IBO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Universal Ibogaine Inc
Accrued Liabilities
Universal Ibogaine Inc
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Universal Ibogaine Inc
XTSX:IBO
|
Accrued Liabilities
497.8k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Universal Ibogaine Inc
Glance View
Universal Ibogaine, Inc. develops ibogaine based drug franchise to treat addiction and related mental health issues. The company is headquartered in Calgary, Alberta. The company went IPO on 2017-06-21. The firm is focused on developing medicines and building a network of holistic recovery clinics for the treatment of addictions. The company treats addictions primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. Its focuses on developing ibogaine for the treatment of opioid use disorders. Ibogaine is a neuroactive compound, which is derived from various plants. Ibogaine helps to repair damaged brain tissues of the patients and helps them to recover and rebuild their lives.
See Also
What is Universal Ibogaine Inc's Accrued Liabilities?
Accrued Liabilities
497.8k
Based on the financial report for Jul 31, 2024, Universal Ibogaine Inc's Accrued Liabilities amounts to 497.8k .
What is Universal Ibogaine Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 1Y
27%
Over the last year, the Accrued Liabilities growth was 27%.
